Toomas Erik Anijärv

PhD student @ Clinical Memory Research Unit, Lund University | Adjunct Fellow @ Thompson Institute, University of the Sunshine Coast.

prof_pic.jpg

I’m a PhD student in the field of neuroimaging and Alzheimer’s disease at the Clinical Memory Research Unit in Lund University :sweden:. Furthermore, I’m an Adjunct Fellow at the Thompson Institute of University of the Sunshine Coast in Australia :australia:. I have a background in biomedical engineering and have obtained a Master’s degree in Medical Technology and Physics from Tallinn University of Technlogy :estonia:.

During my PhD, I’m investigating the early brain functional changes of Alzheimer’s disease continuum using functional ultra-high field magnetic resonance imaging (MRI). My other research interests include examining different electroencephalography (EEG) methods as biomarkers for depression, suicidality, aging, and cognition. :nerd_face:

Most of my code for MRI data analysis can be found on my GitHib as mribrew. My signal processing and analysis work with EEG is available as EEG-pyline: EEG pipeline in Python. I’ve also created a Python package HLR - Hierarchical Linear Regression which allows researchers to perform hierarchical regression with ease in Python using Pandas dataframes. :man_technologist:

Besides my active involvement with neuroscience and neuroimaging research, I am interested in longevity research, history, and space exploration.

news

Oct 20, 2023 Attended a 5-day functional MRI workshop in the Martinos Center for Biomedical Imaging in Boston, USA. :us: :airplane:
Aug 1, 2023 Started my PhD studies at the Clinical Memory Research Unit in the Faculty of Medicine in Lund University where I am going to investigate the early brain functional changes in the Alzheimer’s disease continuum. :brain: :sweden:
Feb 24, 2023 Developed and published a Python package ‘HLR - Hierarchical Linear Regression’. Available on GitHub and PyPI. :sweat_smile: :computer:

selected publications

  1. Spectral changes of EEG following a 6-week low-dose oral ketamine treatment in adults with major depressive disorder and chronic suicidality
    T. E. Anijärv*, A. T. Can*, C. C. Gallay, G. A. Forsyth, M. Dutton, J. S. Mitchell, D. F. Hermens, and J. Lagopoulos
    International Journal of Neuropsychopharmacology, 2023